| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 26, 2025 |
Summit Therapeutics Inc
SMMT
|
BUY |
$35.00
Est. +76%
|
$19.89 | $36.91 |
Target Met
|
$15.42
-22.5%
|
| Oct 24, 2024 |
Arcus Biosciences Inc
RCUS
|
BUY |
$46.00
Est. +164%
|
$17.42 | $18.98 |
Miss
|
$30.33
+74.1%
|
| Sep 27, 2024 |
Summit Therapeutics Inc
SMMT
|
BUY |
$23.00
Est. +10%
|
$20.89 | $36.91 |
Target Met
|
$15.42
-26.2%
|
| Sep 10, 2024 |
ArriVent BioPharma Inc.
AVBP
|
BUY |
$36.00
Est. +29%
|
$27.93 | $36.20 |
Bullseye Hit (±1%)
|
$34.67
+24.1%
|
| Aug 27, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$58.00
Est. +46%
|
$39.80 | $40.25 |
Miss
|
$37.65
-5.4%
|
| Aug 15, 2024 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$34.00
Est. +69%
|
$20.09 | $22.50 |
Miss
|
$21.82
+8.6%
|
| Aug 15, 2024 |
Shattuck Labs Inc
STTK
|
BUY |
$8.00
Est. +156%
|
$3.12 | $3.95 |
Miss
|
$7.05
+126.0%
|
| Aug 15, 2024 |
LENZ Therapeutics Inc.
LENZ
|
BUY |
$32.00
Est. +36%
|
$23.50 | $41.70 |
Target Met
|
$5.89
-74.9%
|
| Nov 08, 2021 |
Fate Therapeutics Inc
FATE
|
BUY |
$87.00
Est. +43%
|
$60.79 | - | - |
$2.92
-95.2%
|
| Nov 03, 2021 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$150.00
Est. +74%
|
$86.00 | - | - |
$33.47
-61.1%
|